SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-097292
Filing Date
2024-08-14
Accepted
2024-08-14 18:01:19
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6190
  Complete submission text file 0000950170-24-097292.txt   7672
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address
Narula Sanjeev (Reporting) CIK: 0001820590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 241209911